-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: keymaster@town.hall.org Originator-Key-Asymmetric: MFkwCgYEVQgBAQICAgADSwAwSAJBALeWW4xDV4i7+b6+UyPn5RtObb1cJ7VkACDq pKb9/DClgTKIm08lCfoilvi9Wl4SODbR1+1waHhiGmeZO8OdgLUCAwEAAQ== MIC-Info: RSA-MD5,RSA, c+X6jLIhMnhcafaCnwm9QzvRISSWirgL1ZNwnZvFZkh0psGC3ePJs7d1uIIZtiQY IbUa7BFPG+BOXSD+Mb2LiQ== 0000927016-95-000124.txt : 19950814 0000927016-95-000124.hdr.sgml : 19950814 ACCESSION NUMBER: 0000927016-95-000124 CONFORMED SUBMISSION TYPE: 10-C PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19950810 FILED AS OF DATE: 19950811 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: ABIOMED INC CENTRAL INDEX KEY: 0000815094 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 042743260 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 10-C SEC ACT: 1934 Act SEC FILE NUMBER: 001-09585 FILM NUMBER: 95561262 BUSINESS ADDRESS: STREET 1: 33 CHERRY HILL DR CITY: DANVERS STATE: MA ZIP: 01923 BUSINESS PHONE: 5087775410 MAIL ADDRESS: STREET 1: 33 CHERRY HILL DRIVE CITY: DANVERS STATE: MA ZIP: 01923 10-C 1 FORM 10-C UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-C REPORT BY ISSUER OF SECURITIES QUOTED ON NASDAQ INTERDEALER QUOTATION SYSTEM FILED PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 13A-17 OR 15D-17 THEREUNDER ABIOMED, Inc. ------------- (Exact name of issuer as specified in charter) 33 Cherry Hill Drive, Danvers, Massachusetts 01923 --------------------------------------------------- (Address of principal executive offices) Issuer's telephone number, including area code (508) 777-5410 -------------- I. CHANGE IN NUMBER OF SHARES OUTSTANDING Indicate any change (increase or decrease) of 5% or more in the number of shares outstanding: 1. Title of security Common Stock -------------------------------------------------------- 2. Number of shares outstanding before the change : 4,891,202 --------- 3. Number of shares outstanding after the change: 5,503,202 ---------- 4. Effective date of change: August 10, 1995 ---------------- 5. Method of change: Specify method (such as merger, acquisition, exchange, distribution, stock split, reverse split, acquisition of stock for treasury, etc.) Conversion of Class A Common Stock ------------------------------------------------------------------------- Give brief description of transaction Shares are being issued in connection ------------------------------------- with the conversion of 612,000 Shares of Class A Common Stock into an equal - -------------------------------------------------------------------------------- number of shares of Common Stock. - -------------------------------------------------------------------------------- II. CHANGE IN NAME OF ISSUER ---------------------------- 1. Name prior to change -------------------------------------------------------- 2. Name after change ----------------------------------------------------------- 3. Effective date of charter amendment changing name --------------------------- 4. Date of shareholder approval of change, if required ------------------------- Date: August 11, 1995 /s/ John F. Thero --------------- ------------------------------- John F. Thero Vice President Finance and Administration Chief Financial Officer -----END PRIVACY-ENHANCED MESSAGE-----